Eevia Health Plc (”Eevia" or "The Company") received a proposal for a reverse takeover (RTO) from Stemtech Corporation[1] (“Stemtech”), a US company, on November 10. The proposal suggests that Eevia buy the US company's assets (“Stemtech Assets”) and issue new shares to the US company, providing that Stemtech will own c. …
